LiveBreach Intelligence: data breaches, leaks & ransomware, tracked as they surfaceOngoing protection: GalaxyWarden →
Recent BreachesData breach tracker

Recent Breaches › pharmagestao.com.br Listed by lockbit3 Ransomware Group

HIGH severityUnverified claimHow we verify

pharmagestao.com.br Listed by lockbit3 Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

RBRecent Breaches Breach Intelligence·February 2, 2023
pharmagestao.com.br Listed by lockbit3 Ransomware Group

Reported February 2, 2023.

HIGH
Severity
February 2, 2023
Disclosed
ShareXLinkedInFacebookRedditWhatsAppTelegram

The pharmagestao.com.br Listed by lockbit3 Ransomware Group (reported February 2, 2023) is an unverified claim; the data involved is undisclosed belonging to roughly unknown people. If you have an account with them, your information may now be circulating on the open web and with data brokers. Here’s exactly what happened, how to check if you were affected, and what to do next.

Severity & verification
HIGH severityUnverified claim
Data types not itemised.
Published on a ransomware group’s leak site — an unverified extortion claim until the named organization or credible reporting corroborates it.
Check your exposure
See every leak and listing tied to your email. We can’t confirm any single incident against the sources we search, so we won’t pretend to. 15-second check, no card, no account. Details go to your inbox.

By running your scan you agree to the Terms and Conditions and the Privacy Policy, and to GalaxyWarden emailing you the results of this scan.

Ransomware groups continue to target mid-sized service providers that sit between larger retail networks and the sensitive operational data those networks generate. In early 2023 one such listing appeared on a LockBit3 leak site, naming the Brazilian firm pharmagestao.com.br. Public detail remains limited, yet the claim alone places the organisation and anyone whose records it handles inside a familiar pattern of double-extortion attacks that have become routine across Latin America and beyond.

According to the available record, pharmagestao.com.br was listed by the LockBit3 ransomware group on 2 February 2023. The group asserts that internal files were exfiltrated. The number of people affected is unknown, and no independent confirmation of the intrusion or the precise contents of the stolen material has been published. For franchisees, employees and partners who rely on the firm’s accounting and management services, the listing is therefore a signal that warrants careful attention rather than panic.

Breaking down the breach

The sole concrete public marker is the LockBit3 leak-site entry dated 2 February 2023. It identifies pharmagestao.com.br as a victim and states that internal files were taken during a ransomware attack. No further technical indicators—initial access vector, dwell time, encryption status, ransom demand or negotiation outcome—have been disclosed in the material available for this report. The scale of the incident, measured either by volume of data or by number of individuals whose information may be involved, is likewise unconfirmed.

Because the listing originates from the threat actor itself, it must be treated as a claim rather than verified fact. Organisations named on such sites sometimes later confirm an intrusion; others dispute the assertion or remain silent. In this case no additional public statements clarifying the events have been incorporated into the record used here. What can be said with certainty is only that the group publicly associated the domain with an alleged exfiltration of internal files on the date given.

Who is lockbit3?

LockBit3 is the third major iteration of a ransomware operation that has functioned as a ransomware-as-a-service platform. Affiliates gain access to networks, deploy the encryptor, and share proceeds with the core developers. The group is known for double-extortion tactics: data are copied before systems are locked, and the threat of public release is used to pressure victims. Leak sites hosted by the operators display victim names, sometimes sample files, and countdown timers. LockBit variants have appeared in incidents across multiple continents and sectors, frequently targeting organisations whose disruption carries operational or regulatory cost. The group’s public communications routinely frame each new listing as proof of a successful breach; outside verification is required before those claims can be accepted as established fact.

Nothing in the present record indicates that LockBit3 issued statements specific to pharmagestao.com.br beyond the listing itself. Any characterisation of motive, ransom amount or subsequent release of data would therefore be speculative and is omitted.

Who is pharmagestao.com.br?

Pharma Gestão Serviços was established to support the accounting, tax, financial and corporate management needs of franchisees within the growing Preço Baixo pharmacy network. In practical terms the firm sits at the administrative centre of a multi-unit retail pharmacy operation, handling bookkeeping, fiscal compliance, treasury functions and related corporate records for independent pharmacy owners who operate under the Preço Baixo banner.

Organisations of this type routinely process invoices, payroll data, tax filings, bank details, supplier contracts and internal correspondence. Because pharmacies deal with regulated goods and serve large numbers of local customers, the administrative layer that supports them becomes an attractive concentration point for financially and personally sensitive information. A breach affecting such a service provider can therefore ripple outward to franchisees, their staff and, indirectly, the communities those pharmacies serve. The consequential nature of the incident stems less from the size of any single pharmacy and more from the centralised role Pharma Gestão occupies.

The information in question

The only data category named in the public record is “internal files exfiltrated in ransomware attack.” No inventory of file types, no sample documents and no confirmation of personal or financial data elements have been released. Exact contents therefore remain unconfirmed.

Firms that supply accounting, tax and corporate-management services to pharmacy franchisees typically hold ledgers, tax identification numbers, bank-account information, payroll records, contracts and internal emails. Whether any of those categories were among the files LockBit3 claims to possess cannot be established from the available facts. Readers should treat every specific assertion about exposed fields as unverified until corroborated by the organisation or by independent forensic reporting.

What's at stake

For individuals whose data may have been held by Pharma Gestão, the practical risks are familiar: possible misuse of financial or identity information, targeted phishing that references real transactions, and the longer-term burden of monitoring accounts and credit files. For franchisees the exposure of internal management files could reveal commercial terms, cash-flow positions or tax strategies that competitors or criminals might exploit. The organisation itself faces operational disruption, potential regulatory scrutiny under Brazilian data-protection rules, and the cost of investigation and remediation—none of which can be quantified from the public record.

Because the number of people affected is unknown and the precise data types are undisclosed, the outer boundary of harm cannot yet be drawn. The prudent stance is to assume that any party who has shared accounting or corporate records with the firm has a legitimate interest in confirming whether their material was involved.

Were you affected?

If you are a franchisee, employee or partner of the Preço Baixo network, or if you have otherwise entrusted financial or corporate records to Pharma Gestão Serviços, consider the following immediate steps:

Public detail on this event remains sparse. Continued attention to official statements from the organisation and to verified reporting will be the most reliable way to determine next actions. Until more is known, measured vigilance is the appropriate response.

AICompiled with AI assistance from public sources and published under our editorial standards.

Editorial & sourcing policy
Recent Breaches is a breach-monitoring service and news aggregator. We do not exfiltrate, host, purchase, or redistribute stolen data, and we do not hold the data claimed in leak-site listings. Incidents are compiled from publicly accessible sources and threat-intelligence platforms and are reported as claims attributed to their source. We promptly correct or remove material shown to be inaccurate — write to support@galaxywarden.com or press@recentbreaches.com.
Check if you’re exposed →

How this breach connects

Company

Attributed to

Method

Companypharmagestao.com.br security record
88/100
DoxxScan™ · Low doxx risk
B 83Good record

1 reported incident on record.

See pharmagestao.com.br’s full breach history →

More recent breaches

palaciodosleiloes.com.br Listed by lockbit3 Ransomware GroupSeptember 28, 2023piramidal.com.br Listed by lockbit3 Ransomware GroupSeptember 16, 2023omegaservicos.com.br Listed by lockbit3 Ransomware GroupMarch 11, 2023siqueiracastro.com.br Listed by lockbit3 Ransomware GroupFebruary 22, 2023

Latest breaches

Read GalaxyWarden’s full analysis of the pharmagestao.com.br Listed by lockbit3 Ransomware Group →

Source: threat-actor leak-site listing

Publicly posted by lockbit — unverified claim, pending independent verification

Breach listings — particularly those originating from ransomware or leak sites — are third-party claims that may be unverified, incomplete, or inaccurate. A listing does not by itself confirm that a breach occurred or that any specific data was exposed. Severity is an automated assessment, not a definitive rating. Verification status is shown where available.

Attributions to threat groups and methods reflect public reporting and, in some cases, unverified claims made by the groups themselves; they may be incomplete or later revised. Recent Breaches and GalaxyWarden are independent and are not affiliated with, and do not endorse, any company or group named on this page. This information is aggregated from public sources for awareness only and is not legal, security, or investment advice.

ShareXLinkedInFacebookRedditWhatsAppTelegram